Developer docs
API playgroundTry for free, no card

Search company profiles

Westendpharma

Full company profile

uuid003gcao

Namestring
Westendpharma
Legal namestring
Westendpharma GmbH
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Westendpharma GmbH is a privately held Swiss healthcare consultancy founded in 2023 and headquartered at Unter Altstadt 3 in Zug, Switzerland. The firm provides B2B professional services to pharmaceutical and biotech companies, with a service portfolio spanning physician engagement, opinion leader training and publication support, campaign and initiative management, scientific therapy recommendation delivery, and end-to-end medication lifecycle support covering clinical development through market access. Its positioning emphasizes connecting patients with new therapies and innovations through a stable network of physicians and opinion leaders, built on personal, trust-based relationships developed over time.

Operationally, the company operates on a professional services revenue model, monetizing through contracts with enterprise pharma and biotech clients rather than selling products or licensing technology. It runs a direct enterprise field-sales motion, targeting medical and commercial leaders within client organizations, and emphasizes its independence and scientific credibility — staff are described as scientists from leading universities offering a "holistic perspective." The firm's technology footprint is modest and primarily infrastructural (Microsoft for IT/cloud, Google Analytics for web tracking); there is no proprietary software platform, no disclosed AI capabilities, and no published pricing. Leadership consists of two managing directors, Götz W. Gleichmann and Sven Christoph Winkler, and the company holds Swiss MWST registration (CHE-289.050.377) under commercial register number CH-170.4.021.219-8. No external funding, parent company, or M&A activity is disclosed in available materials.

Short descriptiontext

Westendpharma GmbH is a Swiss healthcare consultancy that facilitates interaction between pharmaceutical/biotech companies and physicians through medical communications, opinion leader engagement, and campaign management across the drug lifecycle.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersZürich, Switzerland
HQ citystring
Zürich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consultancy services, medical communications, physician engagement, opinion leader training, drug lifecycle support
NAICS code2 codes
  • Other Management Consulting Services541618
  • Management Consulting Services54161
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Consultancy Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Consultancy Services
TypeProfessional Services
Description

Westendpharma provides professional services to pharmaceutical and biotech companies including scientific communication, opinion leader training, publication support, campaign management, and regulatory compliance facilitation. Revenue appears to be generated through service contracts with pharma/biotech clients rather than product sales.

westendpharma.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Westendpharma is a pharmaceutical consultancy that facilitates and enriches interaction between pharmaceutical/biotech companies and physicians (healthcare professionals). It provides professional services across the entire drug lifecycle, including physician engagement, opinion leader training, publication support, campaign and initiative management, regulatory compliance facilitation, market access support, and scientific therapy recommendation services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Westendpharma operates as a single integrated service offering rather than a platform with separate modules. The company provides a comprehensive suite of physician engagement and pharmaceutical support services, including physician engagement facilitation, opinion leader training, publication support, campaign management, medication lifecycle support, and scientific therapy recommendations. These services work together to connect patients with innovations and appropriate physicians while supporting pharmaceutical and biotech companies in bringing new therapies to market. The company positions itself as a driver of new, innovative therapy standards, staffed by scientists from leading universities who serve as independent, holistic partners to physicians.

Product and service5 records
1Physician Engagement Services
CategoryPharmaceutical Consultancy Services
2Opinion Leader Support Services
CategoryPharmaceutical Consultancy Services
3Initiative Management and Campaign Services
CategoryPharmaceutical Consultancy Services
4Medication Lifecycle Support
CategoryPharmaceutical Consultancy Services
5Scientific Therapy Recommendation Services
CategoryPharmaceutical Consultancy Services
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest global CRO and pharma services platform with deep medical-communications, market-access, and real-world evidence capabilities. Westendpharma competes for the same enterprise pharma spend at the opposite end of the size spectrum.

TypeBroad incumbent
Description

Global biopharma services organization combining clinical development with commercial/medical communications. Directly competes with Westendpharma in physician engagement, opinion leader training, and market access support.

TypeDirect peer
Description

Large medical-communications and health advertising network serving pharma and biotech clients globally. Closely aligned with Westendpharma's core offerings around opinion leader engagement, publication support, and campaign execution.

TypeBroad incumbent
Description

Global management consultancy with a large pharma and life sciences practice covering market access, R&D strategy, and commercial transformations. Represents the management-consulting alternative for Westendpharma's enterprise clients.

TypeBroad incumbent
Description

Major CRO with significant commercial and consulting capabilities serving pharma/biotech. Comparable in customer base (enterprise pharma and biotech) and life-cycle service scope.

TypeDirect peer
Description

Specialist medical communications and advisory firm focused on pharma/biotech clients. Directly comparable in scope (medical affairs, communications, market access) and target customers.

TypeDirect peer
Description

Global health and wellness communications network with strong medical-affairs and market-access capabilities serving pharma clients. Directly comparable offering around physician engagement and scientific communications.

TypeDirect peer
Description

Healthcare marketing and medical communications agency serving pharma and biotech. Comparable in enterprise pharma focus and integrated scientific communications + campaign model.

TypeRegional player
Description

German-based medical communications and consulting firm serving pharma clients with medical-affairs, opinion leader, and publication support services. Comparable in DACH-region pharma consultancy focus and service mix.

10med 通 AG
TypeRegional player
Description

Swiss medical communications and consulting firm serving pharma clients with medical-affairs support. Comparable as a DACH/Switzerland-based specialist of similar size and scope to Westendpharma.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Westendpharma

Pharmaceutical Consultancy Serviceswestendpharma.com

Westendpharma GmbH is a Swiss healthcare consultancy that facilitates interaction between pharmaceutical/biotech companies and physicians through medical communications, opinion leader engagement, and campaign management across the drug lifecycle.

What Westendpharma does

Westendpharma GmbH is a privately held Swiss healthcare consultancy founded in 2023 and headquartered at Unter Altstadt 3 in Zug, Switzerland. The firm provides B2B professional services to pharmaceutical and biotech companies, with a service portfolio spanning physician engagement, opinion leader training and publication support, campaign and initiative management, scientific therapy recommendation delivery, and end-to-end medication lifecycle support covering clinical development through market access. Its positioning emphasizes connecting patients with new therapies and innovations through a stable network of physicians and opinion leaders, built on personal, trust-based relationships developed over time.

Operationally, the company operates on a professional services revenue model, monetizing through contracts with enterprise pharma and biotech clients rather than selling products or licensing technology. It runs a direct enterprise field-sales motion, targeting medical and commercial leaders within client organizations, and emphasizes its independence and scientific credibility — staff are described as scientists from leading universities offering a "holistic perspective." The firm's technology footprint is modest and primarily infrastructural (Microsoft for IT/cloud, Google Analytics for web tracking); there is no proprietary software platform, no disclosed AI capabilities, and no published pricing. Leadership consists of two managing directors, Götz W. Gleichmann and Sven Christoph Winkler, and the company holds Swiss MWST registration (CHE-289.050.377) under commercial register number CH-170.4.021.219-8. No external funding, parent company, or M&A activity is disclosed in available materials.

Westendpharma firmographics

Firmographics
Name
Westendpharma
Legal name
Westendpharma GmbH
Website
https://westendpharma.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
51–100 employees
Short description
Westendpharma GmbH is a Swiss healthcare consultancy that facilitates interaction between pharmaceutical/biotech companies and physicians through medical communications, opinion leader engagement, and campaign management across the drug lifecycle.
Ownership category
akta.pro rank

Where Westendpharma is headquartered

Location

Headquarters

HQ city
Zürich
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Westendpharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Healthcare Consultancy Services: Westendpharma provides professional services to pharmaceutical and biotech companies including scientific communication, opinion leader training, publication support, campaign management, and regulatory compliance facilitation. Revenue appears to be generated through service contracts with pharma/biotech clients rather than product sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Westendpharma product offering

Product offering

Core offering

Westendpharma is a pharmaceutical consultancy that facilitates and enriches interaction between pharmaceutical/biotech companies and physicians (healthcare professionals). It provides professional services across the entire drug lifecycle, including physician engagement, opinion leader training, publication support, campaign and initiative management, regulatory compliance facilitation, market access support, and scientific therapy recommendation services.

Product overview

Westendpharma operates as a single integrated service offering rather than a platform with separate modules. The company provides a comprehensive suite of physician engagement and pharmaceutical support services, including physician engagement facilitation, opinion leader training, publication support, campaign management, medication lifecycle support, and scientific therapy recommendations. These services work together to connect patients with innovations and appropriate physicians while supporting pharmaceutical and biotech companies in bringing new therapies to market. The company positions itself as a driver of new, innovative therapy standards, staffed by scientists from leading universities who serve as independent, holistic partners to physicians.

Differentiator

Problem solved

Functional benefit

Products and services

  • Physician Engagement Services
  • Opinion Leader Support Services
  • Initiative Management and Campaign Services
  • Medication Lifecycle Support
  • Scientific Therapy Recommendation Services

Companies that use Westendpharma

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Westendpharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Westendpharma partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Westendpharma competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Largest global CRO and pharma services platform with deep medical-communications, market-access, and real-world evidence capabilities. Westendpharma competes for the same enterprise pharma spend at the opposite end of the size spectrum.
  • Syneos Health: Global biopharma services organization combining clinical development with commercial/medical communications. Directly competes with Westendpharma in physician engagement, opinion leader training, and market access support.
  • McKinsey & Company (Pharma Practice): Global management consultancy with a large pharma and life sciences practice covering market access, R&D strategy, and commercial transformations. Represents the management-consulting alternative for Westendpharma's enterprise clients.
  • ICON plc: Major CRO with significant commercial and consulting capabilities serving pharma/biotech. Comparable in customer base (enterprise pharma and biotech) and life-cycle service scope.

Direct peers

  • Publicis Health: Large medical-communications and health advertising network serving pharma and biotech clients globally. Closely aligned with Westendpharma's core offerings around opinion leader engagement, publication support, and campaign execution.
  • Ashfield Health (part of Inizio): Specialist medical communications and advisory firm focused on pharma/biotech clients. Directly comparable in scope (medical affairs, communications, market access) and target customers.
  • Havas Health & You: Global health and wellness communications network with strong medical-affairs and market-access capabilities serving pharma clients. Directly comparable offering around physician engagement and scientific communications.
  • Mind+Matter (Real Chemistry): Healthcare marketing and medical communications agency serving pharma and biotech. Comparable in enterprise pharma focus and integrated scientific communications + campaign model.

Regional players

  • LEADING BIO: German-based medical communications and consulting firm serving pharma clients with medical-affairs, opinion leader, and publication support services. Comparable in DACH-region pharma consultancy focus and service mix.
  • med 通 AG: Swiss medical communications and consulting firm serving pharma clients with medical-affairs support. Comparable as a DACH/Switzerland-based specialist of similar size and scope to Westendpharma.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Westendpharma social profiles

Digital presence

Westendpharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Westendpharma leadership team

Management profile

Number of profiles

Profiles2 records

Westendpharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Westendpharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Westendpharma

What does Westendpharma do?

Westendpharma is a pharmaceutical consultancy that facilitates and enriches interaction between pharmaceutical/biotech companies and physicians (healthcare professionals). It provides professional services across the entire drug lifecycle, including physician engagement, opinion leader training, publication support, campaign and initiative management, regulatory compliance facilitation, market access support, and scientific therapy recommendation services.

Is Westendpharma a public or private company?

Westendpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Westendpharma founded?

Westendpharma was founded in 2023. It employs 51 to 100 people.

Where is Westendpharma based?

Westendpharma is headquartered in Zürich, Switzerland, in the Europe region.

How does Westendpharma make money?

One revenue line is on record: healthcare Consultancy Services.

Who are Westendpharma's main competitors?

Broad incumbents on record are IQVIA, Syneos Health, McKinsey & Company (Pharma Practice) and ICON plc. Direct peers are Publicis Health, Ashfield Health (part of Inizio), Havas Health & You and Mind+Matter (Real Chemistry). Regional players are LEADING BIO and med 通 AG.

Does Westendpharma have an API?

No public API is recorded for Westendpharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales